By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – OpGen said today that it is working with the Beijing Genomics Institute to expand their use of OpGen's optical mapping technology for de novo sequence finishing in human, plant, and animal genomes.

The company said it has already used its Optical Mapping Technology with BGI to complete a study based on human genome data to successfully close gaps in existing sequence folds.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.